| NCT ID | NCT06203314 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sun Yat-sen University |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 100,000 participants |
| Start Date | 2008-08-01 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100,000 participants in total. It began in 2008-08-01 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this prospective cohort study is to investigate the associations between Epstein-Barr Virus (EBV) antibody levels and the risk of overall and site-specific cancer types in Southern China. The main questions it aims to answer are: Question 1: In addition to the established EBV-associated cancer types, such as lymphomas, nasopharyngeal carcinoma, and stomach cancer, whether EBV is associated with other cancer types? Question 2: What's the cancer burden attributed to EBV in Southern China?
Eligibility Criteria
Inclusion Criteria: * Subject residents in Zhongshan or Wuzhou City; * Subject has no medical record of prevalent cancer; * Subject has psychical condition and well consciousness, and willingness to accept and cooperate with the study\'s follow-up procedures. Exclusion Criteria: * Subject has heavy cardiovascular, liver, or kidney disease; * Subject has prevalent cancer.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06203314 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 69 Years, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06203314 currently recruiting?
Yes, NCT06203314 is actively recruiting participants. Contact the research team at jiawh@sysucc.org.cn for enrollment information.
Where is the NCT06203314 trial being conducted?
This trial is being conducted at Zhongshan, China, Wuzhou, China.
Who is sponsoring the NCT06203314 clinical trial?
NCT06203314 is sponsored by Sun Yat-sen University. The trial plans to enroll 100,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.